Why Johnson & Johnson is a Top 25 Dividend Giant (JNJ)

Johnson & Johnson has been named as a Top 25 Dividend Giant by ETF Channel for a variety of reasons outlined for investors... More 

Don’t Sleep on This Steady Value Stock

JNJ stock is a no-brainer for its diversified play on healthcare, time-tested dividend yield and proven resilience during times of uncertainty. Buy now! More 

58 Last-Minute Trades Before Thanksgiving

Before you head off to your Thanksgiving Holiday, take a look at my latest ratings for these 58 stocks, and make your moves accordingly More 

7 Best Dividend Stocks to Buy for 2016

The best dividend stocks to buy for 2016 offer high yield and low risk. Here are seven that are on the top of the list for income investors. More 

7 Best Index Funds to Hold for the Next Decade

These mutual funds and ETFs could be the best index funds to hold over the coming decade. More 

FDA Approves New J&J Multiple Myeloma Drug Darzalex

The FDA has approved Johnson & Johnson's Darzalex, which is a drug for multiple myeloma patients that have tried other options. More 

PG or JNJ Stock: Which Is Best for Dividend Investors?

PG and JNJ stock may look alike to many investors, but based on price, diversification and other aspects, one is clearly better. More